EGFR and neoplasm: Although cellular EGFR expression, tumor cell density, plasma antibody concentration, and delivery barrier may predict fluorescent antibody distribution in tissue, operating room lighting, imaging device settings, and tumor size and depth can substantially alter the intraoperative fluorescent tumor contrast at specific locations on the tissue surface of each particular patient.